Business Context and Reporting Period
Company: Bruker Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 17, 2008
Reporting Period: The filing references combined financial results for the three and twelve months ended December 31, 2007. These results include the impact of the Bruker BioSpin Group, acquired on February 26, 2008.
Key Financial Metrics
The provided text serves as a cover document referencing a press release (Exhibit 99.1) containing the actual financial data. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
- Revenue/Profit: Not specified in the filing text.
- Cash Flow/Liquidity: Not specified in the filing text.
- Debt: Not specified in the filing text.
Material Changes
The primary material change noted is the inclusion of the Bruker BioSpin Group in the combined financial results for the periods ended December 31, 2007, following its acquisition on February 26, 2008.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, or contingencies. It explicitly states that the information is furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 17, 2008) for specific revenue, earnings, and cash flow figures.
- Verify the pro-forma impact of the Bruker BioSpin Group acquisition on the reported 2007 results.
- Confirm whether the combined results are presented on a GAAP or non-GAAP basis in the attached press release.